Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency

1999 ◽  
Vol 246 (4) ◽  
pp. 265-274 ◽  
Author(s):  
Kirn R. Kessler ◽  
Michael Skutta ◽  
R. Benecke
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Term Treatment ◽  
Toxin A ◽  
Long Term Treatment

Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China

2019 ◽  
Vol 41 (3) ◽  
pp. 645-652
Author(s):  
Xiao-bo Fang ◽  
Meng-shu Xie ◽  
Zu-biao Song ◽  
Zhi-gang Zhong ◽  
Ying Wang ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Southern China ◽  
Botulinum Toxin A ◽  
Term Treatment ◽  
Toxin A ◽  
Long Term Treatment

Botulinum toxin A and cervical dystonia: A long-term monocentric experience

2021 ◽  
Vol 429 ◽  
pp. 119548
Author(s):  
Luca Bosco ◽  
Carla Butera ◽  
Giacomo Sferruzza ◽  
Stefano Amadio ◽  
Roberta Guerriero ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Toxin A

1.254 Long-term follow-up of cervical dystonia patients treated with Botulinum toxin A

2007 ◽  
Vol 13 ◽  
pp. S66
Author(s):  
K. Kollewe ◽  
N. Buhr ◽  
K. Krampfl ◽  
R. Dengler ◽  
B. Mohammadi
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Toxin A ◽  
Long Term Follow Up

Long-term botulinum toxin A treatment in non-primary cervical dystonia

Toxicon ◽  
2018 ◽  
Vol 156 ◽  
pp. S91
Author(s):  
Martina Petracca ◽  
Alessandro De Biase ◽  
Tàmara Ialongo ◽  
Delia Mulas ◽  
Maria Luana Cerbarano ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Toxin A

Long-term follow-up of cervical dystonia patients treated with botulinum toxin A

2003 ◽  
Vol 19 (3) ◽  
pp. 303-308 ◽  
Author(s):  
Peter Haussermann ◽  
Stefanie Marczoch ◽  
Christiane Klinger ◽  
Michael Landgrebe ◽  
Bastian Conrad ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin A ◽  
Toxin A ◽  
Long Term Follow Up

CONDUCTING COMPARATIVE CLINICAL-PHARMACOLOGICAL EVALUATION PHARMACOTHERAPY PREPARATIONS OF BOTULINUM TOXIN A IN CHILDREN WITH CEREBRAL PALSY SYNDROME WITH MARKED SPASTICITY

2019 ◽  
Vol 25 (5-6) ◽  
pp. 293-302
Author(s):  
Anna Petrovna Solovieva ◽  
Vladimir Vladimirovich Arkhipov ◽  
Dmitry Vladimirovich Goryachev
Keyword(s):  
Cerebral Palsy ◽  
Botulinum Toxin ◽  
Botulinum Toxin A ◽  
Pharmacoeconomic Analysis ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Clinical Pharmacological Evaluation

The original methodology for retrospective clinical studies on the criteria of “efficiency/safety” and pharmacoeconomics on the criteria of “cost/effectiveness”is proposed. The results of a retrospective study of medical records in 169 patients with cerebral palsy, which showed that the use of drugs botulinum toxin type A is an important integral component in the long-term treatment of children with spastic forms of cerebral palsy. Presents the results of pharmacoeconomic analysis of the treatment of the syndrome of spasticity in cerebral palsy when used in the complex treatment of Dysport, Botox and Xeomin.

Sign in / Sign up

Export Citation Format

Share Document